← All indications
Vaginal Diseases
Pathological processes of the VAGINA.
Subtype terms (7)
More specific conditions that are subtypes of Vaginal Diseases in the MeSH hierarchy.
- Hematocolpos
- Hydrocolpos
- Vaginal Discharge
7 drugs (6 approved, 1 experimental)
- Vaginal Fistula
1 drug experimental
- Vaginal Neoplasms
59 drugs (36 approved, 23 experimental)
- Vaginismus
1 drug approved
- Vaginitis
36 drugs (23 approved, 13 experimental)
Drugs by status
Approved for this indication (3)
Phase 4 trials (25)
- metronidazole
- urea
- dehydroepiandrosterone
- doxycycline
- sevoflurane
- indocyanine green
- lactobacillus gasseri
- naproxen
- ospemifene
- hyaluronic acid
- levobupivacaine
- ceftriaxone
- desflurane
- estradiol
- autologous microbiome
- azithromycin
- misoprostol
- clindamycin
- estrogen
- clotrimazole
- lactobacillus rhamnosus
- estriol
- conjugated estrogen
- epicatechin
- lactobacillus
Phase 3 trials (12)
Phase 2 trials (16)
Phase 1 trials (4)
Other trials (23)
- diclofenac
- cetearyl alcohol
- desogestrel
- bifidobacterium bifidum
- flax
- lactobacillus fermentum
- lactobacillus helveticus
- triptorelin
- tranexamic acid
- valerianae radix
- Streptococcus thermophilus
- soybean
- chlorhexidine
- omega-3 fatty acids
- Lactobacillus acidophilus
- lactobacillus casei
- saccharomyces cerevisiae
- lactobacillus reuteri
- vaginal fluid
- fb101
- lactobacillus delbrueckii
- human choriogonadotropin alfa
- stryphnodendron
Organizations
Organization Involved with Phase 4 Indications (42)
- Lupin
- Merck
- Merck Serono
- Merck KGaA
- Pfizer
- Sanofi
- Sanofi-Aventis
- Allergan
- Baxalta
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Laboratorios Ordesa
- National Institutes of Health (NIH)
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (NIAID)
- University of Pittsburgh
- BGI Group
- University of London
- Eastern Virginia Medical School
- University of Washington
- Hahnemann University Hospital
- Jawaharlal Nehru Medical College
- Minia University
- Ohio State University
- Skaraborg Hospital
- Thomas Jefferson University
- University of Liverpool
- University of Bern
- Fudan University
- Peking University
- Jiao Tong University
- +12 more
Organization Involved with Phase 3 Indications (34)
- Actavis
- Mission Pharmacal
- Medicis
- Shionogi
- Amvac Kft.
- Avva Rus, JSC
- Biose
- Danone Research
- Embil Pharmaceutical Co. Ltd
- Symbiomix Therapeutics
- Capstone Therapeutics
- Medinova AG
- Starpharma Pty Ltd
- Zodiac Produtos Farmaceuticos S.A.
- National Institute for Medical Research, Tanzania
- Health Decisions
- University of New Mexico
- Wayne State University
- University of British Columbia
- National Institute for Medical Research, Mwanza Research Centre
- Watson Pharmaceuticals
- Sekou-Toure Regional Hospital
- Kirov State Medical Academy
- Hormos Medical
- University of Sherbrooke
- Erasmus University Rotterdam
- University of Western Ontario
- Canadian International Development Agency
- Quatrx Pharmaceuticals Co
- Government of Brazil
- +4 more
Organization Involved with Phase 2 Indications (14)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (21)
- CONRAD
- IBSS Biomed S.A.
- GenMont Biotech Incorporation
- Dartmouth University
- Indiana University
- Stanford University
- University of Kiel
- University of Science Malaysia
- University of South Carolina
- University of Copenhagen
- Medical University of South Carolina
- Kuo General Hospital
- Hebrew University
- Hospitalsenhed Midt
- Dairyfem R&D GmbH
- University of Natural Resources and Life Sciences
- Weizmann Institute of Science
- Vesale Pharma
- Synbio Tech
- Herbarium Laboratorio Botanico Ltda
- Nnamdi Azikiwe University